文献速递免疫规划

10价肺炎球菌结合疫苗(PCV10)接种对鼻咽微生物组的影响

Effects of 10-valent pneumococcal conjugate (PCV10) vaccination on the nasopharyngeal microbiome.
PubMed 文献 · Vaccine · 2019-12-12

研究纳入6-23月龄急性呼吸道感染患儿,比较48名接种与36名未接种PCV10者的鼻咽微生物组。16S rRNA测序及QIIME分析显示两组细菌组成和多样性相似,提示PCV10接种针对疫苗靶标发挥作用,同时保持鼻咽微生物组稳定。

要点

  • 接种与未接种PCV10的患儿鼻咽细菌组成和多样性相似。
  • 接种组链球菌属和嗜血杆菌属增加、莫拉菌属减少,但差异无统计学意义。
  • PCV10接种可能促进针对靶标病原体的特异性反应并诱导共生菌定植。

核心结论

  • PCV10接种针对其靶标病原体发挥特异性作用,并诱导共生菌定植,而未实质改变鼻咽微生物组。

研究设计与样本

  • 研究纳入6-23月龄急性呼吸道感染患儿,分为48名PCV10接种组和36名未接种组,采集鼻咽抽吸物行16S rRNA测序,并以QIIME分析细菌组成。

主要发现

  • 未接种组与接种组样本的细菌组成相似,主成分分析也显示两组细菌组成相似。
  • 接种组与未接种组样本的细菌多样性无差异。
  • 接种组链球菌属和嗜血杆菌属增加、莫拉菌属减少,但差异无统计学意义。
  • 链球菌属的增加可能与疫苗靶标类群被非致病菌种替代有关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pathogenic bacteria, such as Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae and Moraxella catarrhalis, are important vaccine targets. The 10-valent pneumococcal conjugate vaccine (PCV10) acts on 10 differents S. pneumoniae serovars. However, this vaccine could also act on other bacteria genera, leading to dysbiosis. Moreover, the vaccination has also been associated with imbalances in the ratio between commensal and potentially pathogenic bacteria. Despite the wealth of studies assessing the influence of the microbiome on vaccine effects, how vaccination can influence the microbiome remains poorly understood. Herein, we assessed the effects of PCV10 on infant nasopharyngeal microbiome composition. Nasopharyngeal aspirates were collected from children with acute respiratory infection (ARI) aged 6-23 months. Two groups were composed of 48 vaccinated and 36 unvaccinated subjects. 16S ribosomal RNA sequencing was performed to assess bacterial composition and results were analyzed with QIIME. Similar bacterial compositions were observed in the unvaccinated and vaccinated samples. Principal component analysis also indicated a similar bacterial composition between the groups. In addition, bacterial diversity was not different between the vaccinated and unvaccinated samples. Accordingly, our results suggest that PCV10 vaccination promotes a specific response against its targets, thereby preserving the nosocomial microbiome. Although not statistically significant, Streptococcus and Haemophilus genera were increased in the vaccinated group, while Moraxella was decreased. Increases in Streptococcus may be associated with vaccine-target taxa replacement by non-pathogenic species. In sum, we observed that PCV10 vaccination acts by promoting a target-specific action against pathogenic bacteria and also induces commensal bacteria colonization without substantially changing the nasopharyngeal microbiome.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Salgado VR, Fukutani KF, Fukutani E, et al. Effects of 10-valent pneumococcal conjugate (PCV10) vaccination on the nasopharyngeal microbiome. Vaccine. 2019. PMID: 31839468. doi:10.1016/j.vaccine.2019.11.079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。